Study ID: IXR-201-04-142
Study Title
- Efficacy/Safety Study of Nebulized IVX-0142, a Novel AntiFemale, Maleergic Drug, in Mild Female, Maleergic Asthma
Teva Identifier
- IXR-201-04-142
ClinicalTrials.gov Identifier
- NCT00232999
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Nebulized IVX-0142
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 60 Years
Trial Duration
- 10/01/2005 - 01/01/2006
Phase
- Phase 2
Study Type
Interventional